FDA Stresses CBD Safety Concerns in 15 Warning Letters and Revised Consumer Update
The Blunt Truth
DECEMBER 3, 2019
In its largest mass enforcement action involving cannabidiol (CBD) yet, the U.S. Food & Drug Administration (FDA) announced on November 25 the issuance of 15 warning letters to various companies for illegally selling products containing CBD. In addition to the letters, the FDA published a revised Consumer Update detailing safety concerns about CBD products more broadly.